Moderna and CARsgen team up on CAR-T cell therapy and mRNA cancer vaccine combo - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
CARsgen will test its Claudin18.2 CAR T-cell candidate, dubbed CT041, in combination with Moderna’s investigational mRNA cancer vaccine in a collaboration between the two companies. As part of the collaboration, the two candidates will be investigated in prec…